Ausgabe 7/2001
Inhalt (24 Artikel)
Ambulatory blood pressure and heart rate in relation to kidney structure and metabolic control in adolescents with Type I diabetes
T. B. Torbjörnsdotter, G. A. Jaremko, U. B. Berg
Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress
A. Ceriello, F. Mercuri, L. Quagliaro, R. Assaloni, E. Motz, L. Tonutti, C. Taboga
MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice
A. E. Panerai, F. Nicoletti, P. Sacedote, L. Arvidsson, I. Conget, R. Gomis, A. Bartorelli, S. Sandler
High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI
O. Massa, F. Meschi, A. Cuesta-Munoz, A. Caumo, F. Cerutti, S. Toni, V. Cherubini, L. Guazzarotti, N. Sulli, F. M Matschinsky, R. Lorini, D. Iafusco, F. Barbetti
Early cellular and molecular changes induced by diabetes in the retina
M. Lorenzi, C. Gerhardinger
Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension
F. Bonnet, M. E. Cooper, H. Kawachi, T. J. Allen, G Boner, Z. Cao
Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes
K. Levin, H. Daa Schroeder, F. P. Alford, H. Beck-Nielsen
Diet and risk of Type II diabetes: the role of types of fat and carbohydrate
F. B. Hu, R. M. van Dam, S. Liu
The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats
Y. Nagisa, A. Shintani, S. Nakagawa
Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice
V. Ablamunits, M. Bridgett, T. Duffy, F. Haag, M. Nissen, F. Koch-Nolte, H. Leiter
Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children
K. Sadeharju, M. Lönnrot, T. Kimpimäki, K. Savola, S. Erkkilä, T. Kalliokoski, P. Savolainen, P. Koskela, J. Ilonen, O. Simell, M. Knip, H. Hyöty
Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade
S. A. Mifsud, T. J. Allen, J. F. Bertram, U. L. Hulthen, D. J. Kelly, M. E. Cooper, J. L. Wilkinson-Berka, R. E. Gilbert
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat
A. A. F. Sima, W. Zhang, K. Sugimoto, D. Henry, Z. Li, J. Wahren, G. Grunberger
Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999–2000)
P. Y. Benhamou, J. Oberholzer, C. Toso, L. Kessler, A. Penfornis, F. Bayle, C. Thivolet, X. Martin, F. Ris, L. Badet, C. Colin, P. Morel
Isolation and characterization of the human AKT1 gene, identification of 13 single nucleotide polymorphisms (SNPs), and their lack of association with Type II diabetes
A. Matsubara, J. C. Wasson, S. S. Donelan, C. M. Welling, B. Glaser, M. A. Permutt